CASP3 and neoplasm: Increased GIPR expression resulted in significantly reduced cell viability, cell growth, and proliferation, and significantly smaller tumors were formed in in vivo CAM assays as well as significantly increased caspase-3-dependent cell death levels in vitro, mirroring the effects previously seen after TFF1 overexpression [22] and indicating a role of this protein as a tumor suppressor.